Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Business Of Biotech
00:00
The Importance of Bone Tarpetics in Chronic Diseases
The merger of meds, Senek and bone therapeutics feels like or looks like sort of an unlikely combination. But without that context, if you're just looking at the transaction on paper, it's a good one. And we found that in bone tarpetics, they are cells which are coming from the bone marrow and which are undifferentiated. They have what we call an immune privilege. So there is a full path of development here, which is not now, but much later in the next years.
Transcript
Play full episode
